Business Services
Medical
Biotechnology

PRA Health Sciences

$107.72
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.72 (-1.57%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell PRAH and other stocks, options, ETFs, and crypto commission-free!

About

PRA Health Sciences, Inc. engages in the provision of outsourced clinical development services to the biotechnology and pharmaceutical industries. It operates through Clinical Research and Data Solutios segment. Read More The Clinical Research segment serves biopharmaceutical clients and offers outsourced clinical research and clinical trial related services. The Data Solutions segment involves in data and analytics; technology solutions and real-world insights; and services primarily to the company's life science clients. The company was founded in 1976 and is headquartered in Raleigh, NC.

Employees
16,400
Headquarters
Raleigh, North Carolina
Founded
1976
Market Cap
7.04B
Price-Earnings Ratio
46.40
Dividend Yield
0.00
Average Volume
587.41K
High Today
$109.39
Low Today
$107.29
Open Price
$109.21
Volume
276.43K
52 Week High
$121.98
52 Week Low
$79.20

Collections

Business Services
Medical
Biotechnology
Pharmaceutical
Biopharmaceutical
Technology
Health
2014 IPO

News

Yahoo FinanceMar 19

PRAH vs. HQY: Which Stock Should Value Investors Buy Now?

PRAH vs. HQY: Which Stock Is the Better Value Option? Investors interested in stocks from the Medical Services sector have probably already heard of PRA Health Sciences (PRAH) and HealthEquity (HQY). But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank....

9
Yahoo FinanceMar 15

3 Reasons Growth Investors Will Love PRA Health Sciences (PRAH)

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns.

15
TradingNewsNowMar 13

Latest Technicals: PRA Health Sciences (NASDAQ: PRAH)

PRA Health Sciences is part of the healthcare sector and is part of the medical diagnostics and research industry. The company CEO is Colin Shannon. PRA Health Sciences Inc is a United State based full-service global contract research organization. It provides a broad range of product development services for pharmaceutical and biotechnology companies around the world. Previous Intraday Trading Performance: The PRAH stock showed a previous change of 0.35% with an open at 103.21 and a close of 102.87. It r...

9

Earnings

$0.74
$0.93
$1.12
$1.31
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected Apr 24, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.